Breastcancer.org Podcast

The March 2014 Breastcancer.org podcast features Michele Pich, a psychologist and veterinary grief counselor at the University of Pennsylvania School of Veterinary Medicine. Michele also has extensive experience in leading support groups for people diagnosed with cancer. Michele brought along Vivian, her certified therapy dog who has been named Therapy Dog Ambassador for two years in a row at the National Dog Show. Listen to the podcast to hear Michele discuss: the physical and psychological reasons pets are so comforting how the therapy animal world has expanded beyond dogs Michele and Vivian's experiences helping women diagnosed with breast cancer how you can arrange for a visit from a certified therapy animal Running time: 28:51These podcasts, along with all the other vital content and community support at Breastcancer.org, only exist because of the generous donations of listeners like you. Please visit Breastcancer.org/support to learn how you can help keep our services free for you and the millions of

In the first April 2014 Breastcancer.org podcast, Brian Wojciechowski, M.D., Breastcancer.org's medical adviser, talks about some of the most interesting research studies that were published in March 2014. Listen to the podcast to hear Dr. Wojciechowski discuss: the importance of exercise to reduce breast cancer risk the new guidelines for the size of cancer tumor margins available options for women who are having trouble paying for treatment resources for older cancer survivors who might be having sexuality issues how radiation after mastectomy benefits women with one to three positive lymph nodes results from a phase II trial on the experimental medicine palbociclib Running time: 31:20These podcasts, along with all the other vital content and community support at Breastcancer.org, only exist because of the generous donations of listeners like you. Please visit Breastcancer.org/support to learn how you can help keep our services free for you and the millions of women who depend on us.

The second April 2014 Breastcancer.org podcast features Pamela Post-Ferrante, a four-time breast cancer survivor, writer, teacher, and workshop leader. She wrote her book, Writing and Healing: A Mindful Guide for Cancer Survivors, to help others use writing and mindfulness to heal themselves. Listen to the podcast to hear Pamela discuss: how writing helped her heal how the exercises in her book have helped others why therapeutic writing is so powerful Running time: 33:41These podcasts, along with all the other vital content and community support at Breastcancer.org, only exist because of the generous donations of listeners like you. Please visit Breastcancer.org/support to learn how you can help keep our services free for you and the millions of women who depend on us.

In this Breastcancer.org podcast, Kathy Miller, M.D., talks about how breast cancer treatments can affect your stamina and your ability to exercise, as well as how to exercise during treatment. Dr. Miller is a professor of medicine at Indiana University and is the author of more than 60 scientific papers, many of which focus on breast cancer biology and treatment. Dr. Miller also is a member of the Breastcancer.org Professional Advisory Board.Listen to the podcast to hear Dr. Miller talk about: how to figure out what a safe level of exercise is while you’re getting chemotherapy or radiation or recovering from surgery tips on how to start exercising if you’ve never exercised before how treatment can change your stamina the benefits of exercise, including helping women recover from treatment Running time: 21:21These podcasts, along with all the other vital content and community support at Breastcancer.org, only exist because of the generous donations of listeners like you. Please visit Breastcancer.org/suppor

In this Breastcancer.org podcast, Brian Wojciechowski, M.D., Breastcancer.org’s medical adviser, discusses some of the most talked-about studies that came out in April 2014. Listen to the podcast to hear Dr. Wojciechowski explain: the new American Association of Clinical Oncology (ASCO) guidelines on sentinel lymph node biopsy for people diagnosed with early-stage disease more guidelines from ASCO on issues faced by survivors, including chemotherapy-induced neuropathy, fatigue, and depression how healthy eating improves survival why an individualized approach to mammography screening is needed Running time: 27:02 These podcasts, along with all the other vital content and community support at Breastcancer.org, only exist because of the generous donations of listeners like you. Please visit Breastcancer.org/support to learn how you can help keep our services free for you and the millions of women who depend on us.

In this Breastcancer.org podcast, Michael Krychman, M.D. discusses female sexual health and how a breast cancer diagnosis and treatment can affect sexual function and quality of life. Dr. Krychman is executive director of the Southern California Center for Sexual Health and Survivorship Medicine, as well as a clinical sexologist. Dr. Krychman also is writing a new blog for Breastcancer.org called "Sex Matters." Listen to the podcast to hear Dr. Krychman talk about: some of the biggest sexual issues and side effects during and after breast cancer treatment the best way to discuss sexual issues with your doctor, especially if you're not comfortable with the topic the importance of having an individualized survivorship care plan that includes a sexual health component Running time: 27:15 These podcasts, along with all the other vital content and community support at Breastcancer.org, only exist because of the generous donations of listeners like you. Please visit Breastcancer.org/support to learn how you

In this Breastcancer.org podcast, Brian Wojciechowski, M.D., Breastcancer.org medical adviser, discusses some of the research that was published in May 2014 or presented at the American Society of Clinical Oncology Annual Meeting in June 2014. Listen to the podcast to hear Dr. Wojciechowski explain: why using Aromasin on top of ovarian suppression medicine is better at reducing risk in premenopausal women than tamoxifen on top of ovarian suppression medicine why some research studies on any links between vitamin D and breast cancer outcomes seem to have mixed results the American Society of Clinical Oncology special series of articles on pain in people diagnosed with cancer why childhood cancer survivors have a higher risk of breast cancer, even if they didn’t have radiation to the chest area Running time: 21:44 These podcasts, along with all the other vital content and community support at Breastcancer.org, only exist because of the generous donations of listeners like you. Please visit Breastcancer.

In this Breastcancer.org podcast, Suzanne Wardell, Ph.D., talks about how breast cancer drugs are developed and why some drugs never make it to market. Dr. Wardell is a research scientist at Duke University in North Carolina. Her research interests lie in understanding the processes by which breast cancers develop resistance to tamoxifen and aromatase inhibitors and in developing drugs that will target estrogen receptor activity in these resistant tumors. Listen to the podcast to hear Dr. Wardell talk about: bazedoxifene (BZA), a SERM approved in Europe to treat osteoporosis that has been shown to stop the growth of hormone-receptor-positive breast cancer cells the importance of clinical trials new research she's conducting suggesting that women diagnosed with breast cancer who do some form of moderate exercise three times a week while in treatment have better outcomes than women who don’t exercise; this applies to women who didn't exercise before being diagnosed, as well as women who did Running time: 28:09T

This Breastcancer.org podcast focuses on metastatic disease and features Roz Kleban, a licensed clinical social worker who is a clinical supervisor and program coordinator at the Breast Imaging Center at Memorial Sloan Kettering Cancer Center. Roz has worked at Memorial Sloan Kettering since 1989 and works with patients being treated for all stages of breast cancer. Listen to the podcast to hear Roz talk about: why metastatic disease doesn't mean the loss of hope how people with metastatic disease who feel isolated can build a community of people who understand what they're going through how the needs of a woman with metastatic disease are different from the needs of a woman with early-stage disease Running time: 24:00These podcasts, along with all the other vital content and community support at Breastcancer.org, only exist because of the generous donations of listeners like you. Please visit Breastcancer.org/support to learn how you can help keep our services free for you and the millions of women who dep

In this Breastcancer.org podcast, Brian Wojciechowski, M.D., Breastcancer.org medical adviser, discusses some of the research that was published in August and September 2014. Listen to the podcast to hear Dr. Wojciechowski explain: results of a study that found an abnormal PALB2 gene increases breast cancer risk more than previously thought why bisphosphonates don’t reduce risk in women who’ve never been diagnosed with breast cancer the risk-reducing benefits of exercise for postmenopausal women the risks and benefits of double mastectomy versus lumpectomy plus radiation for women at average risk diagnosed with breast cancer in just one breast Running time: 19:34These podcasts, along with all the other vital content and community support at Breastcancer.org, only exist because of the generous donations of listeners like you. Please visit Breastcancer.org/support to learn how you can help keep our services free for you and the millions of women who depend on us.

This Breastcancer.org podcast focuses on not having reconstruction after mastectomy and features Barbara Kriss, the founder of BreastFree.org, a nonprofit website that presents non-reconstruction as a positive alternative to reconstruction. Listen to the podcast to hear Barbara talk about: how she made her decision to not have reconstruction how to handle any pressure to have reconstruction from doctors or loved ones how to ask your doctor for the best possible cosmetic results after mastectomy if you're not going to have reconstruction clothing tips for women who opt for no reconstruction and decide not to wear breast forms Running time: 25:49These podcasts, along with all the other vital content and community support at Breastcancer.org, only exist because of the generous donations of listeners like you. Please visit Breastcancer.org/support to learn how you can help keep our services free for you and the millions of women who depend on us.

In this Breastcancer.org podcast, Pat Prijatel talks about triple-negative breast cancer and what makes it different from other types of breast cancer. Pat Prijatel writes the blog Positives About Negative and is the author of Surviving Triple Negative Breast Cancer. She has been a magazine writer, editor, consultant, and professor for more than 35 years. She headed Drake University's magazine sequence for 22 years before taking over as director of the School of Journalism and Mass Communication in 2004. In May 2006, Pat was diagnosed with early-stage triple-negative breast cancer. She retired from Drake in 2007 to focus on health writing and her health. She had surgery, chemotherapy, and radiation, and is now healthy, fit, and cancer-free.Listen to the podcast to hear Pat talk about: what the idea of triple-negative disease meant to her when she was diagnosed when and why she started her blog what researchers have learned recently about triple-negative disease advice she would give to a woman newly diagnosed

In this Breastcancer.org podcast, Harvey Singer talks about his diagnosis of breast cancer and awareness of male breast cancer in general, especially during October. With his sister Vicki Singer Wolf, a three-time breast cancer survivor, Harvey is the founder of the HISBreastCancer Awareness, Inc. Foundation and HISBreastCancer.org. He also wrote the book Sir, You Have Breast Cancer! My Life and the Story of a Man with a Woman’s Disease.Listen to the podcast to hear Harvey talk about: the shock of his diagnosis how he made his treatment decisions how perceptions of male breast cancer have changed risk reduction advice he recommends for men at high risk Running time: 36:27These podcasts, along with all the other vital content and community support at Breastcancer.org, only exist because of the generous donations of listeners like you. Please visit Breastcancer.org/support to learn how you can help keep our services free for you and the millions of women who depend on us.

In this Breastcancer.org podcast, Brian Wojciechowski, M.D., Breastcancer.org medical adviser, discusses some of the research that was presented at the 2014 San Antonio Breast Cancer Symposium. Listen to the podcast to hear Dr. Wojciechowski explain: results of a study that found that Aromasin plus ovarian suppression reduced recurrence risk better than tamoxifen plus ovarian suppression in some women diagnosed with early-stage, hormone-receptor-positive disease research that underscored the long-term benefits of tamoxifen for reducing risk in women with a higher-than-average risk of breast cancer who’ve never been diagnosed a study showing that Faslodex worked better than Arimidex as a first treatment for women newly diagnosed with advanced-stage breast cancer research conducted in part by Breastcancer.org that shows that breastfeeding, even for a short time, reduces breast cancer risk more than previously thought why a low-fat diet improved survival in women diagnosed with hormone-receptor-negative breast c

In this Breastcancer.org podcast, Brian Wojciechowski, M.D., Breastcancer.org’s medical adviser, discusses Ibrance, a medicine that was approved to treat metastatic, hormone-receptor-positive breast cancer in February 2015. Listen to the podcast to hear Dr. Wojciechowski explain: how Ibrance works who is eligible to take Ibrance how Ibrance is taken and whether any other medicines are taken with it the side effects that Ibrance can cause Running time: 9:55These podcasts, along with all the other vital content and community support at Breastcancer.org, only exist because of the generous donations of listeners like you. Please visit Breastcancer.org/support to learn how you can help keep our services free for you and the millions of women who depend on us.

In this Breastcancer.org podcast, Brian Wojciechowski, M.D., Breastcancer.org’s medical adviser, discusses a study looking at whether Zoladex (chemical name: goserelin) given during chemotherapy can help preserve fertility in premenopausal women diagnosed with early-stage, hormone-receptor-negative breast cancer. Listen to the podcast to hear Dr. Wojciechowski explain: when Zoladex is given why women shouldn’t get pregnant while they’re being treated with chemotherapy and Zoladex why a woman might have to bring this treatment up with her doctor why this treatment is only recommended for women diagnosed with early-stage, hormone-receptor-negative disease Running time: 9:33These podcasts, along with all the other vital content and community support at Breastcancer.org, only exist because of the generous donations of listeners like you. Please visit Breastcancer.org/support to learn how you can help keep our services free for you and the millions of women who depend on us.

This Breastcancer.org podcast features Holley Kitchen, the metastatic “cancer lifer” as she calls herself, whose June 4, 2015 video about what it’s like to live with metastatic breast cancer went viral on Facebook and other media outlets. Holley was diagnosed with stage III breast cancer in 2012. In 2013, she learned that the cancer had recurred in her spine and other bones.Listen to the podcast to hear Holley talk about: why and how she made her now-famous video her support group of other younger women with metastatic disease and why it’s so important to her some of the most common misconceptions about metastatic disease what she’s doing next Running time: 27:04These podcasts, along with all the other vital content and community support at Breastcancer.org, only exist because of the generous donations of listeners like you. Please visit Breastcancer.org/support to learn how you can help keep our services free for you and the millions of women who depend on us.

This Breastcancer.org podcast features Marie Arsenault, a former music promoter and booking agent, who was first diagnosed with stage II estrogen-receptor-positive, HER2-negative breast cancer in September 2000 at age 36. She had mastectomy with TRAM flap reconstruction, chemotherapy, and radiation. In May 2007, she was diagnosed with metastatic disease; the breast cancer had returned in her liver and bones. In 2011, the cancer spread to her bone marrow.Listen to the podcast to hear Marie talk about: how she feels during Breast Cancer Awareness Month what she would like people to know about metastatic breast cancer how her support network helps her stay positive through treatment her volunteer work with the Tenth Life Cat Rescue in St. Louis Running time: 22:06These podcasts, along with all the other vital content and community support at Breastcancer.org, only exist because of the generous donations of listeners like you. Please visit Breastcancer.org/support to learn how you can help keep our services fre

In this Breastcancer.org podcast, Brian Wojciechowski, M.D., Breastcancer.org’s medical adviser, talks about four studies that were presented at the 2015 San Antonio Breast Cancer Symposium, December 8-12, including studies that offer encouraging news about treatment for women diagnosed with triple-negative disease and metastatic, HER2-positive breast cancer. Listen to the podcast to hear Dr. Wojciechowski explain: what luminal A breast cancer is and why women diagnosed with this subtype didn’t seem to benefit from chemotherapy after surgery why adding carboplatin to a standard chemotherapy before surgery for triple-negative breast cancer improved pathologic complete response rates and what this means for women with triple-negative disease why postmenopausal women diagnosed with early-stage, hormone-receptor-positive breast cancer who are taking an aromatase inhibitor and have experienced bone loss might want to consider taking the targeted therapy denosumab results showing that Kadcyla improves overall survi

In this podcast, Marisa Weiss, M.D., Breastcancer.org’s chief medical officer, explains a study that looked at the effectiveness of Arimidex and tamoxifen for reducing risk after DCIS surgery and radiation, as well as the side effects of each medicine. The study was presented at the 2015 San Antonio Breast Cancer Symposium, December 8-12. Listen to the podcast to hear Dr. Weiss explain: what DCIS is why postmenopausal women should be reassured no matter which of these medicines they’re taking the side effects of each medicine Running time: 11:26These podcasts, along with all the other vital content and community support at Breastcancer.org, only exist because of the generous donations of listeners like you. Please visit Breastcancer.org/support to learn how you can help keep our services free for you and the millions of women who depend on us.